De Novo Design of Antigen-Specific Antibodies Using Structural Constraint-Based Generative Language Model

Published: 06 Mar 2025, Last Modified: 26 Apr 2025GEMEveryoneRevisionsBibTeXCC BY 4.0
Track: Biology: datasets and/or experimental results
Nature Biotechnology: Yes
Keywords: Antibody engineering, De novo design, Iterative optimization, Large language model
Abstract: Despite significant advances in computational antibody design, the limited availability of high-quality binding data continues to constrain the exploration of diverse antibody syntax and uncharted evolutionary landscapes. To overcome these challenges, we developed PALM-PA (Pre-trained Antibody Generative Large Language Model–Preference Alignment), which integrates antibody linguistic patterns with structural constraints to explore novel sequence spaces. Experimental validation on influenza A hemagglutinin and programmed death-ligand 1 (PD-L1) demonstrated nanomolar binding affinities (30.2 nM and 1.29 nM, respectively), underscoring the feasibility of using structure-guided language models for the de novo design of antibodies.
Anonymization: This submission has been anonymized for double-blind review via the removal of identifying information such as names, affiliations, and identifying URLs.
Presenter: ~Yuran_Jia1
Format: Maybe: the presenting author will attend in person, contingent on other factors that still need to be determined (e.g., visa, funding).
Funding: No, the presenting author of this submission does *not* fall under ICLR’s funding aims, or has sufficient alternate funding.
Submission Number: 37
Loading